MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s40123-021-00384-9

Медицинская библиотека · Ophthalmology and therapy · 2021

Efficacy of a New Commercial Ocular Spray Containing Oftasecur Citrus Extract for Reducing Microbial Load in the Conjunctiva of Patients Receiving Intravitreal Injections.

Vagge Aldo, Ferro Desideri Lorenzo, Carnevali Adriano, Del Noce Chiara, Camposampiero Davide, Agrusta Marina, Ponzin Diego, Pellegrini Marco, Vaccaro Sabrina, Nicolò Massimo, Scorcia Vincenzo, Traverso Carlo E, Giannaccare Giuseppe

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

The control of conjunctival microbial load is crucial for patients receiving intravitreal injections (IVTs) in order to reduce the risk of endophthalmitis. The purpose of this work was to assess the antimicrobial activity of a new commercial ocular spray containing Biosecur citrus extract (Oftasecur®, Off Health, Florence, Italy).

METHODS

This prospective cross-sectional pilot study included patients receiving IVTs who were instructed to apply Oftasecur spray onto the eye to be injected four times daily starting 4 days before surgery. The contralateral eye was considered the control. A conjunctival swab for microbiological analysis was performed in both eyes before starting study treatment and at the time of the injection. The Brief Ocular Discomfort Inventory (BODI) questionnaire was administered to patients based on an 11-point scale (0 for no discomfort and 10 for maximum discomfort).

RESULTS

Thirty patients (15 male, 15 female; mean age 64.7 ± 11.6 [standard deviation, SD] years) were included. Before starting treatment, 53.3% of the total eyes tested positive during the microbiological analysis. After the treatment period, only 20% of the eyes tested positive at the time of injection, showing a significant reduction in the microbial load (p < 0.01). Moreover, in the treated arm, the positive swabs before and after the prophylactic treatment with Oftasecur ocular spray showed a significant reduction (from 70.4% to 29.6%; p = 0.003, McNemar's test). Oftasecur ocular spray was well tolerated, with an average BODI score of 1.2 (± 0.70 SD).

CONCLUSION

Oftasecur ocular spray showed antimicrobial activity that significantly reduced the microbial load in patients receiving intravitreal injections. Therefore, it may have a role in the prophylaxis of infection in the setting of IVTs.

Для цитирования: Vagge Aldo, Ferro Desideri Lorenzo, Carnevali Adriano, Del Noce Chiara, Camposampiero Davide, Agrusta Marina, Ponzin Diego, Pellegrini Marco, Vaccaro Sabrina, Nicolò Massimo, Scorcia Vincenzo, Traverso Carlo E, Giannaccare Giuseppe. Efficacy of a New Commercial Ocular Spray Containing Oftasecur Citrus Extract for Reducing Microbial Load in the Conjunctiva of Patients Receiving Intravitreal Injections.. Ophthalmology and therapy. 2021. DOI: 10.1007/s40123-021-00384-9.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.